WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will report its financial results for the third quarter of 2008 after the U.S. Financial Markets close on Wednesday, November 5, 2008. Following the announcement, Panacos will hold a conference call to discuss the results, as well as provide a development update. Alan W. Dunton, M.D., President and Chief Executive Officer, will host the call.
